Nuventra’s VP of Clinical Pharmacology and Pharmacokinetics, Mark Bush, Ph.D., will be presenting at the next PBSS San Francisco Symposium titled, “Development of Drug/Device Combinations.” The FDA defines combination products as therapeutic and diagnostic products that combine drugs, devices, and/or biological products.
Dr. Bush will lead a presentation on drug/device combination products from a pharmacokinetic perspective. This symposium will also be offered as a webcast.
Date: February 11, 2020
Time: 8:45am – 5:00pm | Pacific Time
Location: Foster City Crowne Plaza | 1221 Chess Dr. | Foster City, CA
Registration deadline: February 7 (registration will close if seating cap is reached)